NVET
Nexvet Biopharma plc Ordinary Shares
NVET
NVET
Delisted
NVET was delisted on the 28th of July, 2017.
18 hedge funds and large institutions have $30.1M invested in Nexvet Biopharma plc Ordinary Shares in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 8 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
3
Increased
4
Reduced
8
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
CI
Cowen Inc
New York
|
+$161K |
2 |
Bank of America
Charlotte,
North Carolina
|
+$131K |
3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.26K |
4 |
UBS Group
Zurich,
Switzerland
|
+$3.73K |
5 |
NFG
Next Financial Group
Houston,
Texas
|
+$3K |
Top Sellers
1 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
-$1.03M |
2 |
Jennison Associates
New York
|
-$264K |
3 |
Millennium Management
New York
|
-$153K |
4 |
SIM
Spark Investment Management
New York
|
-$123K |
5 |
Norges Bank
Oslo,
Norway
|
-$46.1K |